Zecardio Therapeutics opens EUR 0.8m funding round through Capital Cell
Zecardio Therapeutics abre una ronda de financiación de EUR 0,8m a través de Capital Cell
Intel ID : 281929
|
||||
| Intel ID | 281929 | |||
| Value | EUR 0,80m | |||
| Native Currency | Euro (EUR) | |||
| Date |
 |
|||
| Country |  |
|||
| Geography | |
|||
| Subsector (Old TTR Sectors) |
|
|||
| Type |
|
|||
| Intel Grade |
|
|||
| Source |
|
|||
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.99 Other Biotechnology & Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
15.06.01 Colleges & Universities 15 Consumer Products & Services / 15.06 Education & Training Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Radar
| Date | Title | Type | Intel Grade | Country | Subsector | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mergers & Acquisitions
| Date | Target | Country | Buyer | Seller | VALUE (EURm) | Subsector | |||
|
|
|
|
|
- |
|
|
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.